75 related articles for article (PubMed ID: 7787940)
1. Pharmacogenetics and development: are infants and children at increased risk for adverse outcomes?
Kearns GL
Curr Opin Pediatr; 1995 Apr; 7(2):220-33. PubMed ID: 7787940
[TBL] [Abstract][Full Text] [Related]
2. Developmental pharmacology.
van den Anker JN
Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761
[TBL] [Abstract][Full Text] [Related]
3. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
Murray M
J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics-guided dose modifications of antidepressants.
Seeringer A; Kirchheiner J
Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics and pharmacogenomics.
Leeder JS
Pediatr Clin North Am; 2001 Jun; 48(3):765-81. PubMed ID: 11411304
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics: has it reached the clinic?
Schwartz JB
J Gend Specif Med; 2002; 5(2):13-8. PubMed ID: 11974670
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics in biological perspective.
Kalow W
Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics and pharmacogenomics. Searching for individual antihypertensive therapy concepts].
Brand E
MMW Fortschr Med; 2003 May; 145(19):43-4. PubMed ID: 12813978
[No Abstract] [Full Text] [Related]
9. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 pharmacogenetics and cancer.
Rodriguez-Antona C; Ingelman-Sundberg M
Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacogenetics and its importance in the clinical].
Lares-Asseff I; Trujillo-Jiménez F
Gac Med Mex; 2001; 137(3):227-36. PubMed ID: 11432091
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
14. [Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping].
Johansen PW; Bergan S; Rootwelt H; Kvittingen EA; Rugstad HE
Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2781-3. PubMed ID: 12523145
[TBL] [Abstract][Full Text] [Related]
15. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
Sikka R; Magauran B; Ulrich A; Shannon M
Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
[TBL] [Abstract][Full Text] [Related]
16. Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis.
Kennedy MJ; Scripture CD; Kashuba AD; Scott CS; Gaedigk A; Kearns GL
Clin Pharmacol Ther; 2004 Mar; 75(3):163-71. PubMed ID: 15001967
[TBL] [Abstract][Full Text] [Related]
17. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
Kearns GL
Ann Pharmacother; 1993 Jan; 27(1):74-9. PubMed ID: 8431626
[TBL] [Abstract][Full Text] [Related]
18. Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children.
de Wildt SN
Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):935-48. PubMed ID: 21548840
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacogenetic determinants and considerations in chemotherapy selection and dosing in infants.
Hutson JR; Weitzman S; Schechter T; Arceci RJ; Kim RB; Finkelstein Y
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):709-22. PubMed ID: 22509821
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in pediatrics. Implications for practice.
Leeder JS; Kearns GL
Pediatr Clin North Am; 1997 Feb; 44(1):55-77. PubMed ID: 9057784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
